AFT Pharmaceuticals (ASX:AFP) Scaled Net Operating Assets : 0.70 (As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is AFT Pharmaceuticals Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

AFT Pharmaceuticals's operating assets for the quarter that ended in Sep. 2023 was A$140.9 Mil. AFT Pharmaceuticals's operating liabilities for the quarter that ended in Sep. 2023 was A$44.6 Mil. AFT Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2023 was A$137.7 Mil. Therefore, AFT Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2023 was 0.70.

AFT Pharmaceuticals Scaled Net Operating Assets Historical Data

The historical data trend for AFT Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Scaled Net Operating Assets Chart

AFT Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.73

0.93

0.83

0.86

0.87

AFT Pharmaceuticals Semi-Annual Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Scaled Net Operating Assets	Get a 7-Day Free Trial											0.77	0.82	0.39	0.89	0.70

Competitive Comparison of AFT Pharmaceuticals's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AFT Pharmaceuticals's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where AFT Pharmaceuticals's Scaled Net Operating Assets falls into.

AFT Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

AFT Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2023 )
=	(Operating Assets (A: Mar. 2023 )	-	Operating Liabilities (A: Mar. 2023 ))	/	Total Assets (A: Mar. 2022 )
=	(133.261	-	34.168)	/	113.397
=	0.87

where

	Operating Assets		(A: Mar. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	137.677	-	4.416
=	133.261

	Operating Liabilities		(A: Mar. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	69.549	-	32.564	-	2.817
=	34.168

AFT Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2023 )
=	(Operating Assets (Q: Sep. 2023 )	-	Operating Liabilities (Q: Sep. 2023 ))	/	Total Assets (Q: Mar. 2023 )
=	(140.926	-	44.618)	/	137.677
=	0.70

where

	Operating Assets		(Q: Sep. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	146.622	-	5.696
=	140.926

	Operating Liabilities		(Q: Sep. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	78.415	-	33.797	-	0
=	44.618

AFT Pharmaceuticals Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

AFT Pharmaceuticals (ASX:AFP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (ASX:AFP) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

AFT:New Zealand

Address

129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622

Website

https://www.aftpharm.com

AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

AFT Pharmaceuticals (ASX:AFP) Headlines

No Headlines